Differential expression of certain genes, such as CHI3L1, MEG3, FOS, and CCL4L2, were observed between these subclusters, along with differential enrichment of crucial pathways, including cell communication, cell differentiation, immune response, and inflammatory response, indicating significant intratumor heterogeneity within glioma samples. The gene discussed is CCL4L2; the disease is central nervous system cancer.